BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 28517225)

  • 1. SU-E-T-425: Impact of Model Based Dose Calculation Algorithm for Ir-192 Intracavitary Brachytherapy with Shielded Applicator.
    Mikell J; Klopp A; Price M; Mourtada F
    Med Phys; 2012 Jun; 39(6Part16):3802. PubMed ID: 28517225
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of heterogeneity-based dose calculation using a deterministic grid-based Boltzmann equation solver for intracavitary brachytherapy.
    Mikell JK; Klopp AH; Gonzalez GM; Kisling KD; Price MJ; Berner PA; Eifel PJ; Mourtada F
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):e417-22. PubMed ID: 22436788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commissioning of a grid-based Boltzmann solver for cervical cancer brachytherapy treatment planning with shielded colpostats.
    Mikell JK; Klopp AH; Price M; Mourtada F
    Brachytherapy; 2013; 12(6):645-53. PubMed ID: 23891341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of prototype shielded cervical intracavitary brachytherapy applicators compatible with CT and MR imaging.
    Price MJ; Jackson EF; Gifford KA; Eifel PJ; Mourtada F
    Med Phys; 2009 Dec; 36(12):5515-24. PubMed ID: 20095264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SU-E-T-318: Source Position Localization for ICBT Tandem & Ovoid Applicators Utilizing Oncentra Brachy Applicator Modeling.
    Kemp J; Price M
    Med Phys; 2012 Jun; 39(6Part14):3777. PubMed ID: 28517249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dosimetric evaluation of image based brachytherapy using tandem ovoid and tandem ring applicators.
    Rangarajan R
    Rep Pract Oncol Radiother; 2018; 23(1):57-60. PubMed ID: 29348735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dosimetric impact of an 192Ir brachytherapy source cable length modeled using a grid-based Boltzmann transport equation solver.
    Mikell JK; Mourtada F
    Med Phys; 2010 Sep; 37(9):4733-43. PubMed ID: 20964191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
    Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
    Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
    Beriwal S; Kim H; Heron DE; Selvaraj R
    Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric comparison of Acuros™ BV with AAPM TG43 dose calculation formalism in breast interstitial high-dose-rate brachytherapy with the use of metal catheters.
    Sinnatamby M; Nagarajan V; Reddy K S; Karunanidhi G; Singhavajala V
    J Contemp Brachytherapy; 2015 Aug; 7(4):273-9. PubMed ID: 26622230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of heterogeneity-corrected dose calculation using a grid-based Boltzmann solver on breast and cervix cancer brachytherapy.
    Hofbauer J; Kirisits C; Resch A; Xu Y; Sturdza A; Pötter R; Nesvacil N
    J Contemp Brachytherapy; 2016 Apr; 8(2):143-9. PubMed ID: 27257419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SU-E-T-427: Effect of Contrast in Radiadyne Alatus Balloon Packing System on Bladder and Rectal Doses in Gynecological Brachytherapy.
    Libby B; Ding K; Reardon K; Crandley E; Andrew C; Schneider B
    Med Phys; 2012 Jun; 39(6Part16):3803. PubMed ID: 28517197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Dosimetric evaluation of a high dose rate cobalt-60 brachytherapy source using shielded, single and multi-channel cylinder applicators for gynecological cancers.
    Abtahi M; Safaei AM; Sheikhzade P; Gholami S
    Med Dosim; 2022 Winter; 47(4):318-324. PubMed ID: 35907692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the validity of the superposition principle in dose calculations for intracavitary implants with shielded vaginal colpostats.
    Markman J; Williamson JF; Dempsey JF; Low DA
    Med Phys; 2001 Feb; 28(2):147-55. PubMed ID: 11243337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric accuracy of a deterministic radiation transport based (192)Ir brachytherapy treatment planning system. Part III. Comparison to Monte Carlo simulation in voxelized anatomical computational models.
    Zourari K; Pantelis E; Moutsatsos A; Sakelliou L; Georgiou E; Karaiskos P; Papagiannis P
    Med Phys; 2013 Jan; 40(1):011712. PubMed ID: 23298082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of "optimized" treatment planning for tandem and ring, and tandem and ovoids, using high dose rate brachytherapy for cervical cancer.
    Noyes WR; Peters NE; Thomadsen BR; Fowler JF; Buchler DA; Stitt JA; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):79-86. PubMed ID: 7995771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric impact of applicator displacement on three-dimensional image-guided high-dose-rate brachytherapy treatments for cervical cancer.
    Jayarathna S; Hoang M; Badkul R; Hoover A
    J Contemp Brachytherapy; 2023 Oct; 15(5):334-343. PubMed ID: 38026073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetric analysis of a shielded applicator for nasopharyngeal carcinoma intracavitary brachytherapy: Monte Carlo calculation.
    Chen LX; Liu XW; You RA; Qian JY; Qi ZY; Deng XW; Tsao SY
    Med Phys; 2006 Mar; 33(3):761-9. PubMed ID: 16878578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.